178 related articles for article (PubMed ID: 34364939)
1. Type F mutation of nucleophosmin 1 Acute Myeloid Leukemia: A tale of disorder and aggregation.
La Manna S; Florio D; Di Natale C; Scognamiglio PL; Sibillano T; Netti PA; Giannini C; Marasco D
Int J Biol Macromol; 2021 Oct; 188():207-214. PubMed ID: 34364939
[TBL] [Abstract][Full Text] [Related]
2. Type C mutation of nucleophosmin 1 acute myeloid leukemia: Consequences of intrinsic disorder.
La Manna S; Florio D; Di Natale C; Lagreca E; Sibillano T; Giannini C; Marasco D
Biochim Biophys Acta Gen Subj; 2022 Aug; 1866(8):130173. PubMed ID: 35597503
[TBL] [Abstract][Full Text] [Related]
3. The acute myeloid leukemia-associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C-terminal domain.
La Manna S; Scognamiglio PL; Roviello V; Borbone F; Florio D; Di Natale C; Bigi A; Cecchi C; Cascella R; Giannini C; Sibillano T; Novellino E; Marasco D
FEBS J; 2019 Jun; 286(12):2311-2328. PubMed ID: 30921500
[TBL] [Abstract][Full Text] [Related]
4. Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia.
La Manna S; Florio D; Di Natale C; Napolitano F; Malfitano AM; Netti PA; De Benedictis I; Marasco D
Bioorg Chem; 2021 Aug; 113():104997. PubMed ID: 34044346
[TBL] [Abstract][Full Text] [Related]
5. Proteostasis unbalance of nucleophosmin 1 in Acute Myeloid Leukemia: An aggregomic perspective.
Di Natale C; Florio D; Di Somma S; Di Matteo A; Federici L; Netti PA; Morelli G; Malfitano AM; Marasco D
Int J Biol Macromol; 2020 Dec; 164():3501-3507. PubMed ID: 32890557
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia.
Di Natale C; La Manna S; Malfitano AM; Di Somma S; Florio D; Scognamiglio PL; Novellino E; Netti PA; Marasco D
Biochim Biophys Acta Proteins Proteom; 2019 Jun; 1867(6):637-644. PubMed ID: 30710643
[TBL] [Abstract][Full Text] [Related]
7. Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia.
Florio D; Roviello V; La Manna S; Napolitano F; Maria Malfitano A; Marasco D
Bioorg Chem; 2022 Oct; 127():106001. PubMed ID: 35803020
[TBL] [Abstract][Full Text] [Related]
8. Insights into amyloid-like aggregation of H2 region of the C-terminal domain of nucleophosmin.
Russo A; Diaferia C; La Manna S; Giannini C; Sibillano T; Accardo A; Morelli G; Novellino E; Marasco D
Biochim Biophys Acta Proteins Proteom; 2017 Feb; 1865(2):176-185. PubMed ID: 27865970
[TBL] [Abstract][Full Text] [Related]
9. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
10. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
Zhu G; Luo H; Feng Y; Guryanova OA; Xu J; Chen S; Lai Q; Sharma A; Xu B; Zhao Z; Feng R; Ni H; Claxton D; Guo Y; Mesa RA; Qiu Y; Yang FC; Li W; Nimer SD; Huang S; Xu M
Nat Commun; 2021 Mar; 12(1):1956. PubMed ID: 33782403
[TBL] [Abstract][Full Text] [Related]
11. Nucleophosmin contains amyloidogenic regions that are able to form toxic aggregates under physiological conditions.
Di Natale C; Scognamiglio PL; Cascella R; Cecchi C; Russo A; Leone M; Penco A; Relini A; Federici L; Di Matteo A; Chiti F; Vitagliano L; Marasco D
FASEB J; 2015 Sep; 29(9):3689-701. PubMed ID: 25977257
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia.
Shi Y; Xue Y; Wang C; Yu L
Hematology; 2022 Dec; 27(1):609-619. PubMed ID: 35621728
[TBL] [Abstract][Full Text] [Related]
13. Amyloid fibers deriving from the aromatic core of C-terminal domain of nucleophosmin 1.
La Manna S; Roviello V; Scognamiglio PL; Diaferia C; Giannini C; Sibillano T; Morelli G; Novellino E; Marasco D
Int J Biol Macromol; 2019 Feb; 122():517-525. PubMed ID: 30389521
[TBL] [Abstract][Full Text] [Related]
14. Could Targeting NPM1c+ Misfolding Be a Promising Strategy for Combating Acute Myeloid Leukemia?
Florio D; Marasco D
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255885
[TBL] [Abstract][Full Text] [Related]
15. Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.
Zarka J; Short NJ; Kanagal-Shamanna R; Issa GC
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32545659
[TBL] [Abstract][Full Text] [Related]
16. Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.
Martelli MP; Rossi R; Venanzi A; Meggendorfer M; Perriello VM; Martino G; Spinelli O; Ciurnelli R; Varasano E; Brunetti L; Ascani S; Quadalti C; Cardinali V; Mezzasoma F; Gionfriddo I; Milano F; Pacini R; Tabarrini A; Bigerna B; Albano F; Specchia G; Vetro C; Di Raimondo F; Annibali O; Avvisati G; Rambaldi A; Falzetti F; Tiacci E; Sportoletti P; Haferlach T; Haferlach C; Falini B
Blood; 2021 Dec; 138(25):2696-2701. PubMed ID: 34343258
[TBL] [Abstract][Full Text] [Related]
17. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.
Federici L; Falini B
Protein Sci; 2013 May; 22(5):545-56. PubMed ID: 23436734
[TBL] [Abstract][Full Text] [Related]
18. A Curious Novel Combination of
Venanzi A; Rossi R; Martino G; Annibali O; Avvisati G; Mameli MG; Sportoletti P; Tiacci E; Falini B; Martelli MP
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573408
[No Abstract] [Full Text] [Related]
19. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
20. Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1.
Florio D; La Manna S; Di Natale C; Leone M; Mercurio FA; Napolitano F; Malfitano AM; Marasco D
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]